http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107156106-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-154 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-15003 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-150343 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N1-0226 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1003 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N1-021 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-154 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N1-02 |
| filingDate | 2017-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107156106-B |
| titleOfInvention | Stabilizer for circulating tumor nucleic acid and cells in liquid biopsy blood and blood collection tube thereof |
| abstract | The invention provides a stabilizer for circulating tumor nucleic acid and cells in liquid biopsy blood and a blood collection tube thereof. The stabilizer comprises, by weight, 20-100 parts of preservative, 5-50 parts of antioxidant, 1-35 parts of anticoagulant, 5-20 parts of pH stabilizer, 5-20 parts of enzyme inhibitor, 0.1-10 parts of apoptosis inhibitor, 5-25 parts of free radical scavenger and 1-10 parts of metabolism inhibitor. The stabilizing agent for circulating tumor nucleic acid and cells in liquid biopsy blood and the blood collection tube thereof provided by the invention can be used for quickly separating related samples by using a one-step method, can effectively preserve fetal free nucleic acid, prevent crosslinking damage of circulating tumor nucleic acid, ensure the integrity of wild type genes, prevent cell lysis and release of blood genome nucleic acid thereof, and realize normal-temperature preservation and transportation of circulating tumor cells, lymphocytes and circulating tumor nucleic acid in blood samples of cancer patients. |
| priorityDate | 2017-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 138.